Cargando…

A target based approach identifies genomic predictors of breast cancer patient response to chemotherapy

BACKGROUND: The efficacy of chemotherapy regimens in breast cancer patients is variable and unpredictable. Whether individual patients either achieve long-term remission or suffer recurrence after therapy may be dictated by intrinsic properties of their breast tumors including genetic lesions and co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hallett, Robin M, Pond, Gregory, Hassell, John A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441237/ https://www.ncbi.nlm.nih.gov/pubmed/22578285 http://dx.doi.org/10.1186/1755-8794-5-16

Ejemplares similares

Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy
por: Hallett, Robin M., et al.
Publicado: (2015)

Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
por: Dias, Kay, et al.
Publicado: (2017)

Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts
por: Gwynne, William D, et al.
Publicado: (2017)

E2F1 and KIAA0191 expression predicts breast cancer patient survival
por: Hallett, Robin M, et al.
Publicado: (2011)

A program to identify prognostic and predictive gene signatures
por: Chorlton, Sam D, et al.
Publicado: (2014)

Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer
por: Hallett, Robin M, et al.
Publicado: (2014)

A Gene Signature for Predicting Outcome in Patients with Basal-like Breast Cancer
por: Hallett, Robin M., et al.
Publicado: (2012)

Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer
por: Hallett, Robin M., et al.
Publicado: (2012)

Identification and evaluation of network modules for the prognosis of basal-like breast cancer
por: Hallett, Robin M., et al.
Publicado: (2015)

Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer
por: Hallett, Robin M., et al.
Publicado: (2016)

An algorithm to discover gene signatures with predictive potential
por: Hallett, Robin M, et al.
Publicado: (2010)

Monoamine oxidase-A activity is required for clonal tumorsphere formation by human breast tumor cells
por: Gwynne, William D., et al.
Publicado: (2019)

Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review
por: Xu, Weilin, et al.
Publicado: (2020)

Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer
por: Ali, H. Raza, et al.
Publicado: (2016)

Genome‐Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β‐Blockers
por: Shahin, Mohamed H., et al.
Publicado: (2018)

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
por: Tynninen, O, et al.
Publicado: (2002)

Gene expression profile-based predictors of response to chemotherapy
por: Pusztai, L
Publicado: (2005)

The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures
por: Cockburn, Jessica G., et al.
Publicado: (2016)

Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice
por: Robichaux, Jacqulyne P., et al.
Publicado: (2014)

Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Kim, Kwan Il, et al.
Publicado: (2014)

Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients
por: Sasanpour, Pegah, et al.
Publicado: (2018)

Preoperative Breast Magnetic Resonance Imaging as a Predictor of Response to Neoadjuvant Chemotherapy
por: Browne, Robert, et al.
Publicado: (2022)

Novel peripheral blood parameters as predictors of neoadjuvant chemotherapy response in breast cancer
por: Yang, Gaohua, et al.
Publicado: (2022)

NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer
por: Mullan, Paul B., et al.
Publicado: (2019)

Single Unpurified Breast Tumor-Initiating Cells from Multiple Mouse Models Efficiently Elicit Tumors in Immune-Competent Hosts
por: Kurpios, Natasza A., et al.
Publicado: (2013)

Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapy
por: Jiang, Cui, et al.
Publicado: (2019)

Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
por: Lips, Esther H., et al.
Publicado: (2015)

Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Nakashoji, Ayako, et al.
Publicado: (2017)

Genomic approaches to identifying targets for treating β hemoglobinopathies
por: Ngo, Duyen A., et al.
Publicado: (2015)

Survivin, Ki-67 and tumor grade as predictors of response to docetaxel-based neoadjuvant chemotherapy in locally advanced breast cancer
por: LIN, QI, et al.
Publicado: (2013)

A Systematic Evaluation of Multi-Gene Predictors for the Pathological Response of Breast Cancer Patients to Chemotherapy
por: Shen, Kui, et al.
Publicado: (2012)

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
por: Tanioka, M, et al.
Publicado: (2010)

Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response
por: Lee, Ho-chang, et al.
Publicado: (2013)

Predictors of axillary node response in node-positive patients undergoing neoadjuvant chemotherapy for breast cancer
por: Ladak, Farah, et al.
Publicado: (2022)

Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients
por: Freeman, Jincong Q., et al.
Publicado: (2023)

Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach
por: Tadayyon, Hadi, et al.
Publicado: (2016)

A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response
por: Cardoso, Marcella Regina, et al.
Publicado: (2018)

A systematic analysis of genomics-based modeling approaches for prediction of drug response to cytotoxic chemotherapies
por: Mannheimer, Joshua D., et al.
Publicado: (2019)

Parametric survival model to identify the predictors of breast cancer mortality: An accelerated failure time approach
por: Iraji, Zeinab, et al.
Publicado: (2020)

Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
por: Shehata, M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gj17t8tkf3klo0vqraj3t45cki